Abstract
Rheumatology key message:
Autoimmune events may arise following therapy with MAPK/ERK pathway inhibitors.
Autoimmune events may arise following therapy with MAPK/ERK pathway inhibitors.
Original language | English |
---|---|
Journal | Rheumatology (Oxford) |
Early online date | 30 Mar 2018 |
DOIs | |
Publication status | E-pub ahead of print - 30 Mar 2018 |